A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT05911841. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 52 Week Study to Evaluate the Efficacy and Safety of LY3454738 in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to describe the efficacy and safety of LY3454738 in adult participants with moderate-to-severe atopic dermatitis (AD).
Study identification
- NCT ID
- NCT05911841
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2023
- Primary completion
- Oct 9, 2024
- Completion
- Mar 13, 2025
- Last update posted
- Dec 1, 2025
2023 – 2025
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| Arkansas Research Trials | North Little Rock | Arkansas | 72217 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Encore Medical Research | Hollywood | Florida | 33024 | — |
| Conquest Research | Winter Park | Florida | 32789 | — |
| Allergy and Asthma Specialist | Owensboro | Kentucky | 42301 | — |
| Revival Research Institute, LLC | Troy | Michigan | 48084 | — |
| ActivMed Practices & Research, Inc. | Portsmouth | New Hampshire | 03801 | — |
| Metropolitan Dermatology - Clark | Kenilworth | New Jersey | 07033 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| DermDox Centers for Dermatology | Camp Hill | Pennsylvania | 17011 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05911841, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05911841 live on ClinicalTrials.gov.